• 48-month project funded by the French National Cancer Institute (INCa) through the “Projets libres de recherche «Biologie et Sciences du Cancer»” call.
  • Congratulations to Mohamed Elati and Wajdi Dhifli for being nominated at the University of Lille, Full professor and Associate professor respectively.
  • This study highlights the relevance of our CoRegNet tool for identifying phases corresponding to changes in physiological state and experimentally validates the impact of six of the nine regulators identified on lipid accumulation. Scooped by Life Sciences UPSaclay.
  • Best Paper Award (Bronze) @ The 16th International Conference on Bioinformatics (INCOB 2017)
  • Congratulations to our 3 team members Pauline Trébulle, François Bucchini and Shawez Khan for being awarded PhD fellowships in iSSB/INRA (IDEX), VIB Ghent (Marie Curie) and VIB, KU Leuven, respectively.
  • New paper in the NAR 2016 web server issue for the GREAT web portal.
  • Mohamed Elati is one of the winners of the national call for proposal ITMO Cancer Aviesan-INSERM "Systems Biology and cancer", part of the "plan cancer 2014-2019" set by the French government, for his multidisciplinary project "LIONs" (Large-scale Integrative approach to unravel the relationships between differentiatiON and tumorigenesiS)
  • The i3-bionet research group is now live!
  • Mohamed Elati was interviewed by the University of Evry Val d'Essonne to speak about the LIONS project. Click on the title to read more!


Big Data Analysis, Machine Learning and Network Bioscience Research meet in our team: we try to rationalize the comprehension of complex genotype–phenotype interactions through a computational biology cycle, that we call “I3-BioNet”, composed of three building blocks: the Inference (DATA/LEARN), Interrogation (MINE/ANALYSE) and genomic Implementation (DESIGN/TEST) of regulatory networks.
We particularly pursue multi-disciplinary projects that aim to 1) determine how transcription factor networks function and evolve in response to cellular differentiation, disease heterogeneity, and treatment. 2) cellular engineering for usueful purposes.

Our team receives significant external funding from the European Union and French National Science Foundation (ITMO Cancer, INCa, ANR, …).

Learn more on the I3-BioNet project page !

The I3-BioNet cycle